News & Blog

News & Blog

  • Reset
News | May 29 2020

Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics

Industry News
News | Mar 20 2020

Design Therapeutics Launches with $45 Million to Develop a New Class of Disease-Modifying Therapies for Serious Degenerative Disorders

Industry News
Blog | Feb 24 2020

Meet the Community: Sahithi Dingari

Community
Blog | Feb 17 2020

Meet the Community: Glenn ter Borg & Katia Gomes

Community
Blog | Feb 10 2020

Meet the Community: Nadine Kleine

Community
Blog | Jan 24 2020

Meet the Community: Lily Pierce

Community
Blog | Jan 20 2020

Meet the Community: Hasitha Illa

Community
Blog | Jan 13 2020

Meet the Community: Rishipal Singh Hura

Community
Blog | Jan 6 2020

Meet the Community: Nara Fernandes Lucio

Community
News | Dec 18 2019

Chondrial Therapeutics Announces Dosing of First Patients in Phase 1 Clinical Program of CTI-1601 for Treatment of Friedreich’s Ataxia

Industry News
News | Nov 13 2019

Minoryx Therapeutics receives Orphan Drug Designation from the European Commission for leriglitazone in the treatment of Friedreich’s Ataxia

Industry News
News | Oct 17 2019

Minoryx Therapeutics receives FDA Orphan Drug Designation for leriglitazone in Friedreich’s Ataxia

Industry News